MODIFIZIERTE NEUROLEPTANALGESIE MIT BUPRENORPHIN = NEUROLEPTANALGESIE MODIFIEE PAR LA BUPRENORPHINEWEIDLER B; VORMANN BV; SEIM M et al.1982; ANAESTH., INTENSIVTHER., NOTFALLMED.; ISSN 0174-1837; DEU; DA. 1982; VOL. 17; NO 6; PP. 319-324; ABS. ENG; BIBL. 36 REF.Article

L'ADMINISTRATION DE BUPRENORPHINE DANS L'ANESTHESIE EQUILIBREEHANAOKA K; KUGIMIYA T; OGAWA K et al.1981; MASUI; ISSN 0021-4892; JPN; DA. 1981; VOL. 30; NO 10; PP. 1034-1040; ABS. ENG; BIBL. 11 REF.Article

BUPRENORPHINE SUPPRESSES HEROIN USE BY HEROIN ADDICTSMELLO NK; MENDELSON JH.1980; SCIENCE; USA; DA. 1980; VOL. 207; NO 4431; PP. 657-659; BIBL. 11 REF.Article

The novel depot of buprenorphine propionate has a long-acting effect on physical dependence on morphineLIU, Kuo-Sheng; LIN, Ching-Nan; SHIEH, Ja-Ping et al.Drug development research. 2006, Vol 67, Num 5, pp 462-469, issn 0272-4391, 8 p.Article

ADMINISTRATION DE BUPRENORPHINE AU COURS DE L'ANESTHESIE GENERALE: EXPLORATION DE LA RESPIRATION, DE L'HEMODYNAMIQUE, EFFETS ANALGESIQUES ET EFFETS SECONDAIRESKWANG HEE LEE; NIOKA S; YODA K et al.1981; MASUI; ISSN 0021-4892; JPN; DA. 1981; VOL. 30; NO 10; PP. 1041-1046; ABS. ENG; BIBL. 9 REF.Article

UNE COMPARAISON ENTRE LA PENTAZOCINE ET LA BUPRENORPHINE DANS L'ANESTHESIE ANALGESIQUEMOMOSE T; ITO K; ENOMOTO N et al.1981; MASUI; ISSN 0021-4892; JPN; DA. 1981; VOL. 30; NO 10; PP. 1053-1061; ABS. ENG; BIBL. 30 REF.Article

BUPRENORPHINE: EXPERIENCE IN AN ELDERLY POPULATION OF 975 PATIENTS DURING A YEAR'S MONITORED RELEASEHARCUS AW; WARD AE; SMITH DW et al.1980; BRIT. J. CLIN. PRACT.; GBR; DA. 1980; VOL. 34; NO 5; PP. 144-146; BIBL. 4 REF.Article

Serious overdoses involving buprenorphine in HelsinkiBOYD, T; RANDELL, T; LUURILA, H et al.Acta anaesthesiologica scandinavica. 2003, Vol 47, Num 8, pp 1031-1033, issn 0001-5172, 3 p.Article

Buprenorphine Metabolites, Buprenorphine-3-glucuronide and Norbuprenorphine-3-glucuronide, Are Biologically ActiveBROWN, Sarah M; HOLTZMAN, Michael; KIM, Thomas et al.Anesthesiology (Philadelphia). 2011, Vol 115, Num 6, pp 1251-1260, issn 0003-3022, 10 p.Article

ANALGESIE PAR VOIE PERIDURALE. COMPARAISON DE LA MORPHINE ET DE LA BUPRENORPHINESARDNAL F; MANEGLIA R; COUSIN MT et al.1983; CAHIERS D'ANESTHESIOLOGIE; ISSN 0007-9685; FRA; DA. 1983; VOL. 31; NO 5; PP. 459-462; BIBL. 15 REF.Article

EFFETS CARDIOVASCULAIRES DE LA BUPRENORPHINETSUNODA Y; SAKANISHI N; NAKAGAWA M et al.1982; MASUI; ISSN 0021-4892; JPN; DA. 1982; VOL. 31; NO 2; PP. 133-138; ABS. ENG; BIBL. 13 REF.Article

EIN FALL VON SEKUNDAERER BUPRENORPHIN (TEMGESIC^REG.) ABHAENGIGKEIT = UN CAS DE DEPENDANCE SECONDAIRE A LA BUPRENORPHINE (TEMGESIC)BENOS J.1983; NERVENARZT; ISSN 0028-2804; DEU; DA. 1983; VOL. 54; NO 5; PP. 259-261; ABS. ENG; BIBL. 4 REF.Article

INTRAVENOUS BUPRENORPHINE (TEMGESIC): USE FOLLOWING FENTANYL ANALGESIC ANAESTHESIAROBERTSON DH; LAING AW.1980; CLIN. TRIALS J.; GBR; DA. 1980; VOL. 17; NO 2; PP. 51-55; BIBL. 9 REF.Article

Taux de pénétration des génériques de la buprénorphine haut dosage: principales tendances de 2006 à 2008 = National and Regional Market Penetration Rates of Generic's High Dosage Buprenorphine: Its Evolution from 2006 to 2008BOCZEK, Christelle; FRAUGER, Elisabeth; MICALLEF, Joëlle et al.Thérapie (Paris). 2012, Vol 67, Num 2, pp 129-136, issn 0040-5957, 8 p.Article

BuprenorphineFOSTER, Bethany; TWYCROSS, Robert; MIHALYO, Mary et al.Journal of pain and symptom management. 2013, Vol 45, Num 5, pp 939-949, issn 0885-3924, 11 p.Article

Gender differences in pharmacokinetics of maintenance dosed buprenorphineMOODY, David E; FANG, Wenfang B; MORRISON, Jerdravee et al.Drug and alcohol dependence. 2011, Vol 118, Num 2-3, pp 479-483, issn 0376-8716, 5 p.Article

PHARMACOCINETIQUE DE LA BUPRENORPHINE INTRAVEINEUSE CHEZ DES MALADES ANESTHESIES PAR N₂O-BUPRENORPHINEAOKI Y; TASHIRO C.1982; MASUI; ISSN 0021-4892; JPN; DA. 1982; VOL. 31; NO 2; PP. 129-132; ABS. ENG; BIBL. 12 REF.Article

The Pharmacokinetic and Pharmacodynamic Interactions Between Buprenorphine/Naloxone and Elvitegravir/ Cobicistat in Subjects Receiving Chronic Buprenorphine/ Naloxone TreatmentBRUCE, Robert Douglas; WINKLE, Peter; CUSTODIO, Joseph M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 4, pp 480-484, issn 1525-4135, 5 p.Article

THE OPIATE ANALGESIC BUPRENORPHINE DECREASES PROLIFERATION OF ADULT HIPPOCAMPAL NEUROBLASTS AND INCREASES SURVIVAL OF THEIR PROGENYPETTIT, A. S; DESROCHES, R; BENNETT, S. A. L et al.Neuroscience. 2012, Vol 200, pp 211-222, issn 0306-4522, 12 p.Article

Novel depots of buprenorphine prodrugs have a long-acting antinociceptive effectLIU, Kuo-Sheng; TZENG, Jann-Inn; CHEN, Yu-Wen et al.Anesthesia and analgesia. 2006, Vol 102, Num 5, pp 1445-1451, issn 0003-2999, 7 p.Article

Buprenorphine use : The international experiencePATRIZIA CARRIERI, Maria; AMASS, Leslie; LUCAS, Gregory M et al.Clinical infectious diseases. 2006, Vol 43, issn 1058-4838, S197-S215, SUP4Conference Paper

Opioid Syndrome: Failed Opioid Therapy for Chronic Noncancer PainKAMEN, Leonard B; FEEKO, Kristofer J.Physical medicine and rehabilitation clinics in North America. 2014, Vol 25, Num 2, issn 1047-9651, 375-395, ix [22 p.]Article

Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV CareCHAUDHRY, Amina A; BOTSKO, Michael; WEISS, Linda et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 56, issn 1525-4135, S14-S21, SUP1Article

The synthesis of buprenorphine intermediates by regioselective microbial N- and O-demethylation reactions using Cunninghamella echinulata NRRL 1384ABEL, Anthony M; CARNELL, Andrew J; DAVIS, J. Alf et al.Enzyme and microbial technology. 2003, Vol 33, Num 5, pp 743-748, issn 0141-0229, 6 p.Article

Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel studyAHMADI, J; AHMADI, K; OHAERI, J et al.European journal of clinical investigation. 2003, Vol 33, Num 9, pp 824-829, issn 0014-2972, 6 p.Article